Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire

NCT03080298 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoactive Sexual Desire Disorder (HSDD)

Interventions

DRUG: BP101
DRUG: Placebo

Sponsor

Ivix LLX